Agency classClass IIOur severity:Moderate FDA (Drugs)·D-0068-2025·Announced 2024-12-04

Equate Maximum Strength Lidocaine Pain Relieving Patches Recalled for Manufacturing Deviations

Equate Maximum Strength Lidocaine Pain Relieving Patches (4%) are being recalled due to current Good Manufacturing Practice deviations. Approximately 1.1 million patches were distributed nationwide in the US.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 2/5 (Moderate).

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: FDA Class II voluntary recall with no reported illnesses or injuries. The recall addresses manufacturing process deviations rather than a documented product defect with evidence of consumer harm.

Plain-English summary

Equate Maximum Strength Lidocaine Pain Relieving Patches containing 4% lidocaine are subject to recall due to manufacturing quality deviations at the production facility. The recalled product includes 1,101,600 patches distributed nationwide in the United States. The patches are sold in boxes of 6 and identified by NDC 79903-106-06 and UPC 681131071277.

Unexo Life Sciences Private Limited, the manufacturer, initiated this voluntary recall following identification of current Good Manufacturing Practice (cGMP) deviations. The FDA classified the recall as Class II. The company notified distributors by letter on October 24, 2024, and the recall was terminated on September 16, 2025.

The patches were distributed by Walmart Inc. nationwide in the United States. Consumers who possess this product should cease use and dispose of it or return it to the retailer. Consumers with questions about the recall should contact Walmart or their healthcare provider.

The recalled product

Product: EQUATE PAIN RELIEVING PATCHES (LIDOCAINE 4%)
Brand: EQUATE PAIN RELIEVING PATCHES
Manufacturer: Unexo Life Sciences Private Limited
Category: Drug — Topical Anesthetic
Hazard: quality-control-failure
Affected units: 1,101,600

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

UPC 6 81131 07127 7

UPCs (1)

681131071277

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 11 recalled by Unexo Life Sciences Private Limited under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 11 products in this recall →

Same manufacturer · Unexo Life Sciences Private Limited

See all →

Moderate
Topical menthol back patch recalled for manufacturing deviations
FDA (Drugs) · 2024-12-04
Moderate
Parche Leon pain relief patches recalled for manufacturing deviations
FDA (Drugs) · 2024-12-04
Moderate
FDA Recalls Menthol Medicated Patches Due to Manufacturing Deviations
FDA (Drugs) · 2024-12-04
Moderate
FDA Recalls Cheeky Bonsai Menthol Pain Relief Patches for Manufacturing Deviations
FDA (Drugs) · 2024-12-04
Moderate
JR Watkins Menthol Pain Relief Patches Recalled for Manufacturing Deviations
FDA (Drugs) · 2024-12-04

Same hazard · quality control failure